Cooper Shares Outstanding 2010-2024 | COO

Cooper shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Cooper shares outstanding for the quarter ending January 31, 2024 were 0.200B, a 0.6% increase year-over-year.
  • Cooper 2023 shares outstanding were 0.199B, a 0.2% increase from 2022.
  • Cooper 2022 shares outstanding were 0.199B, a 0.2% decline from 2021.
  • Cooper 2021 shares outstanding were 0.199B, a 0.4% increase from 2020.
Cooper Annual Shares Outstanding
(Millions of Shares)
2023 199
2022 199
2021 199
2020 198
2019 200
2018 199
2017 198
2016 196
2015 197
2014 196
2013 199
2012 197
2011 193
2010 186
2009 182
Cooper Quarterly Shares Outstanding
(Millions of Shares)
2024-01-31 200
2023-10-31 199
2023-07-31 200
2023-04-30 199
2023-01-31 199
2022-10-31 199
2022-07-31 198
2022-04-30 199
2022-01-31 200
2021-10-31 199
2021-07-31 199
2021-04-30 199
2021-01-31 199
2020-10-31 198
2020-07-31 198
2020-04-30 198
2020-01-31 199
2019-10-31 200
2019-07-31 200
2019-04-30 200
2019-01-31 200
2018-10-31 199
2018-07-31 199
2018-04-30 198
2018-01-31 196
2017-10-31 198
2017-07-31 198
2017-04-30 198
2017-01-31 198
2016-10-31 196
2016-07-31 196
2016-04-30 196
2016-01-31 195
2015-10-31 197
2015-07-31 197
2015-04-30 197
2015-01-31 196
2014-10-31 196
2014-07-31 196
2014-04-30 195
2014-01-31 196
2013-10-31 199
2013-07-31 199
2013-04-30 198
2013-01-31 199
2012-10-31 197
2012-07-31 197
2012-04-30 196
2012-01-31 195
2011-10-31 193
2011-07-31 196
2011-04-30 193
2011-01-31 190
2010-10-31 186
2010-07-31 186
2010-04-30 185
2010-01-31 184
2009-10-31 182
2009-07-31 183
2009-04-30 182
2009-01-31 181
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.341B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.379B 20.59
Becton Dickinson (BDX) United States $68.292B 19.32
West Pharmaceutical Services (WST) United States $25.906B 46.43
Cardinal Health (CAH) United States $24.133B 13.80
Align Technology (ALGN) United States $20.439B 39.46
Labcorp (LH) United States $17.753B 15.28
Henry Schein (HSIC) United States $9.553B 16.99
DENTSPLY SIRONA (XRAY) United States $5.872B 15.20
Merit Medical Systems (MMSI) United States $4.758B 26.08
Patterson (PDCO) United States $2.308B 11.06
CONMED (CNMD) United States $2.301B 20.87
STAAR Surgical (STAA) United States $2.098B 80.57
Atrion (ATRI) United States $0.819B 43.73
Lifevantage (LFVN) United States $0.086B 11.11
Pro-Dex (PDEX) United States $0.067B 33.62
Biolase (BIOL) United States $0.005B 0.00